Assignee
SANFORD BURNHAM MED RES INST
US·30 granted patents·20 pending applications·125 citations·filing 2000–2022
Top patents by PatentIndex Score
50 records- 0194US7964402B2Methods for culture and production of single cell populations of human embryonic stem cellsSANFORD BURNHAM MED RES INST·Filed 2007·Granted Jun 21, 2011·56 cites·22 claims
- 0290US8367621B2Methods and compositions related to internalizing RGD peptidesSANFORD BURNHAM MED RES INST·Filed 2009·Granted Feb 5, 2013·16 cites·21 claims
- 0390US7927816B2Methods for identifying modulators of apoptosisSANFORD BURNHAM MED RES INST·Filed 2008·Granted Apr 19, 2011·11 cites·13 claims
- 0489US7935785B2Selective substrates for matrix metalloproteinasesSANFORD BURNHAM MED RES INST·Filed 2008·Granted May 3, 2011·11 cites·24 claims
- 0587US10047119B2Inhibitor of apoptosis protein (IAP) antagonistsSANFORD BURNHAM MED RES INST·Filed 2016·Granted Aug 14, 2018·5 cites·7 claims
- 0685US10300074B2Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapySANFORD BURNHAM MED RES INST·Filed 2015·Granted May 28, 2019·4 cites·7 claims
- 0785US9982023B2Compositions and methods for treating autoimmune and inflammatory disordersSANFORD BURNHAM MED RES INST·Filed 2012·Granted May 29, 2018·3 cites·28 claims
- 0881US9969726B2Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereofSANFORD BURNHAM MED RES INST·Filed 2015·Granted May 15, 2018·2 cites·6 claims
- 0980US9320810B2HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cellsSANFORD BURNHAM MED RES INST·Filed 2013·Granted Apr 26, 2016·2 cites·15 claims
- 1079US8951971B2Lymphatic zip codes in tumors and pre-malignant lesionsSANFORD BURNHAM MED RES INST·Filed 2013·Granted Feb 10, 2015·2 cites·16 claims
- 1177US9115170B2Methods and compositions related to internalizing RGD peptidesSANFORD BURNHAM MED RES INST·Filed 2013·Granted Aug 25, 2015·3 cites·16 claims
- 1277US8048983B2HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cellsSANFORD BURNHAM MED RES INST·Filed 2008·Granted Nov 1, 2011·2 cites·44 claims
- 1376US7910370B2Methods of using BCL-2 for the therapeutic treatment and prevention of diseasesSANFORD BURNHAM MED RES INST·Filed 2007·Granted Mar 22, 2011·1 cites·15 claims
- 1475US9994915B2miR-211 expression and related pathways in human melanomaSANFORD BURNHAM MED RES INST·Filed 2016·Granted Jun 12, 2018·1 cites·8 claims
- 1574US8017326B2Methods of modulating cell death based on the Bit-1/AES regulatory pathwaySANFORD BURNHAM MED RES INST·Filed 2008·Granted Sep 13, 2011·3 cites·41 claims
- 1673US9884826B2Sulfonamide compounds and uses as TNAP inhibitorsSANFORD BURNHAM MED RES INST·Filed 2016·Granted Feb 6, 2018·1 cites·17 claims
- 1771US8034901B2Bcl-G polypeptides, encoding nucleic acids and methods of useSANFORD BURNHAM MED RES INST·Filed 2009·Granted Oct 11, 2011·0 cites·21 claims
- 1870US8987213B2Peptides that selectively home to heart vasculature and related conjugates and methodsSANFORD BURNHAM MED RES INST·Filed 2013·Granted Mar 24, 2015·0 cites·14 claims
- 1968US10259844B2Endometriosis cell targeting peptide and uses thereofSANFORD BURNHAM MED RES INST·Filed 2015·Granted Apr 16, 2019·1 cites·31 claims
- 2068US7846681B2Apoptosis modulator BCL-B and methods for making and using sameSANFORD BURNHAM MED RES INST·Filed 2009·Granted Dec 7, 2010·0 cites·14 claims
- 2166US7994282B2Card proteins involved in cell death regulationSANFORD BURNHAM MED RES INST·Filed 2007·Granted Aug 9, 2011·0 cites·8 claims
- 2266US2023173097A1Methods and compositions related to peptides and proteins with c-terminal elementsSANFORD BURNHAM MED RES INST·Filed 2022·Application pending·0 cites
- 2364US9957484B2Methods for promoting cell reprogrammingSANFORD BURNHAM MED RES INST·Filed 2014·Granted May 1, 2018·0 cites·9 claims
- 2464US7919317B2Methods of differentiating and protecting cells by modulating the P38/MEF2 pathwaySANFORD BURNHAM MED RES INST·Filed 2001·Granted Apr 5, 2011·1 cites·20 claims
- 2563US7982023B2Bag proteins and nucleic acid molecules encoding themSANFORD BURNHAM MED RES INST·Filed 2010·Granted Jul 19, 2011·0 cites·6 claims
- 2660US7999069B2EphB receptor-binding peptidesSANFORD BURNHAM MED RES INST·Filed 2009·Granted Aug 16, 2011·0 cites·15 claims
- 2760US7927832B2Nucleic acid encoding proteins involved in protein degradation, products and methods related theretoSANFORD BURNHAM MED RES INST·Filed 2008·Granted Apr 19, 2011·0 cites·8 claims
- 2860US2021260202A1Methods and Compositions Related to Annexin 1-Binding CompoundsSANFORD BURNHAM MED RES INST·Filed 2021·Application pending·0 cites
- 2960US2013183241A1Peptides that home to tumor lymphatic vasculature and methods of using sameSANFORD BURNHAM MED RES INST·Filed 2012·Application pending·0 cites
- 3058US2016022831A1Peptides that Selectively Home to Heart Vasculature and Related Conjugates and MethodsSANFORD BURNHAM MED RES INST·Filed 2015·Application pending·0 cites
- 3157USRE42700EInduction of apoptosis in cancer cellsSANFORD BURNHAM MED RES INST·Filed 2008·Granted Sep 13, 2011·0 cites·34 claims
- 3255US2011071213A1Card-domain containing polypeptides, encoding nucleic acids, and methods of useSANFORD BURNHAM MED RES INST·Filed 2010·Application pending·0 cites
- 3355US2011230364A1Methods for identifying modulators of apoptosisSANFORD BURNHAM MED RES INST·Filed 2011·Application pending·0 cites
- 3454US2011189711A1Paad domain-containing polypeptides, encoding nucleic acids, and methods of useSANFORD BURNHAM MED RES INST·Filed 2010·Application pending·0 cites
- 3553US2011201780A1Novel death domain proteinsSANFORD BURNHAM MED RES INST·Filed 2011·Application pending·0 cites
- 3653US2014134231A1Mir-211 expression and related pathways in human melanomaSANFORD BURNHAM MED RES INST·Filed 2013·Application pending·0 cites
- 3749US10099993B2Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereofSANFORD BURNHAM MED RES INST·Filed 2015·Granted Oct 16, 2018·0 cites·24 claims
- 3847US7951544B1Method for determining the prognosis of cancer patients by measuring levels of bag expressionSANFORD BURNHAM MED RES INST·Filed 2000·Granted May 31, 2011·0 cites·15 claims
- 3945US2013225427A1Method for prediction of response to immune mediated disease therapeuticsSANFORD BURNHAM MED RES INST·Filed 2012·Application pending·0 cites
- 4044US2014005181A1Small molecule antagonists of the apelin receptor for the treatment of diseaseSANFORD BURNHAM MED RES INST·Filed 2013·Application pending·0 cites
- 4142US2013210124A1Determination of cancer predispositionSANFORD BURNHAM MED RES INST·Filed 2013·Application pending·0 cites
- 4241US2011067126A1Gab1 involvement in glucose homeostasis regulation by hepatocytesSANFORD BURNHAM MED RES INST·Filed 2010·Application pending·0 cites
- 4341US2011189137A1Method for generation and regulation of ips cells and compositions thereofSANFORD BURNHAM MED RES INST·Filed 2010·Application pending·0 cites
- 4438US9266828B2Inhibitors of Furin and other pro-protein convertasesSANFORD BURNHAM MED RES INST·Filed 2013·Granted Feb 23, 2016·0 cites·11 claims
- 4538US2011171291A1Pathologically-activated therapeuticsSANFORD BURNHAM MED RES INST·Filed 2011·Application pending·0 cites
- 4636US2015051138A1Inhibitors of furin and other pro-protein convertasesSANFORD BURNHAM MED RES INST·Filed 2013·Application pending·0 cites
- 4735US2011081293A1Methods and compositions related to clot-binding lipid compoundsSANFORD BURNHAM MED RES INST·Filed 2010·Application pending·0 cites
- 4834US2011257233A1Benzoisothiazolones as inhibitors of phosphomannose isomeraseSANFORD BURNHAM MED RES INST·Filed 2011·Application pending·0 cites
- 4934US2011229496A1Method for regulating survival and memory of t helper 1 cellsSANFORD BURNHAM MED RES INST·Filed 2011·Application pending·0 cites
- 5033US2018127464A1Novel epha4 inhibitors targeting its ligand binding domainSANFORD BURNHAM MED RES INST·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SANFORD BURNHAM MED RES INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →